Annual SG&A
$49.91 M
-$7.94 M-13.73%
31 December 2023
Summary:
Adverum Biotechnologies annual selling, general & administrative expenses is currently $49.91 million, with the most recent change of -$7.94 million (-13.73%) on 31 December 2023. During the last 3 years, it has risen by +$5.27 million (+11.81%). ADVM annual SG&A is now -22.54% below its all-time high of $64.44 million, reached on 31 December 2021.ADVM Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$9.78 M
+$6.00 M+158.44%
30 September 2024
Summary:
Adverum Biotechnologies quarterly selling, general & administrative expenses is currently $9.78 million, with the most recent change of +$6.00 million (+158.44%) on 30 September 2024. Over the past year, it has dropped by -$4.01 million (-29.06%). ADVM quarterly SG&A is now -55.39% below its all-time high of $21.93 million, reached on 30 June 2021.ADVM Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$3.82 B
-$94.11 M-2.53%
30 September 2024
Summary:
Adverum Biotechnologies TTM selling, general & administrative expenses is currently -$3.82 billion, with the most recent change of -$94.11 million (-2.53%) on 30 September 2024. Over the past year, it has dropped by -$3.87 billion (-7618.42%). ADVM TTM SG&A is now -42943.80% below its all-time high of $66.20 million, reached on 30 September 2021.ADVM TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADVM Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.7% | -29.1% | -7618.4% |
| 3 y3 years | +11.8% | -32.3% | -5866.9% |
| 5 y5 years | +103.2% | +32.4% | -10000.0% |
ADVM Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -22.5% | +11.8% | -43.1% | +158.4% | -71.8% | at low |
| 5 y | 5 years | -22.5% | +103.2% | -55.4% | +158.4% | -178.3% | at low |
| alltime | all time | -22.5% | +9212.5% | -55.4% | +6837.6% | <-9999.0% | at low |
Adverum Biotechnologies Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $9.78 M(+158.4%) | $35.88 M(-10.0%) |
| June 2024 | - | $3.79 M(-66.9%) | $39.88 M(-17.9%) |
| Mar 2024 | - | $11.43 M(+5.0%) | $48.56 M(-2.7%) |
| Dec 2023 | $49.91 M(-13.7%) | $10.88 M(-21.1%) | $49.91 M(-1.7%) |
| Sept 2023 | - | $13.79 M(+10.6%) | $50.78 M(-6.3%) |
| June 2023 | - | $12.47 M(-2.5%) | $54.17 M(-2.3%) |
| Mar 2023 | - | $12.78 M(+8.8%) | $55.47 M(-4.1%) |
| Dec 2022 | $57.86 M(-10.2%) | $11.74 M(-31.7%) | $57.86 M(-0.3%) |
| Sept 2022 | - | $17.19 M(+24.9%) | $58.01 M(+4.9%) |
| June 2022 | - | $13.76 M(-9.3%) | $55.28 M(-12.9%) |
| Mar 2022 | - | $15.17 M(+27.5%) | $63.45 M(-1.5%) |
| Dec 2021 | $64.44 M(+44.4%) | $11.89 M(-17.7%) | $64.44 M(-2.7%) |
| Sept 2021 | - | $14.45 M(-34.1%) | $66.20 M(+4.9%) |
| June 2021 | - | $21.93 M(+35.7%) | $63.10 M(+21.9%) |
| Mar 2021 | - | $16.16 M(+18.4%) | $51.76 M(+16.0%) |
| Dec 2020 | $44.64 M(+57.3%) | $13.65 M(+20.3%) | $44.64 M(+13.7%) |
| Sept 2020 | - | $11.35 M(+7.1%) | $39.27 M(+11.2%) |
| June 2020 | - | $10.60 M(+17.2%) | $35.31 M(+10.9%) |
| Mar 2020 | - | $9.04 M(+9.2%) | $31.84 M(+12.2%) |
| Dec 2019 | $28.38 M(+15.5%) | $8.28 M(+12.0%) | $28.38 M(+12.2%) |
| Sept 2019 | - | $7.39 M(+3.6%) | $25.28 M(+11.3%) |
| June 2019 | - | $7.13 M(+27.9%) | $22.72 M(-8.3%) |
| Mar 2019 | - | $5.58 M(+7.5%) | $24.77 M(+0.8%) |
| Dec 2018 | $24.56 M | $5.19 M(+7.5%) | $24.56 M(+4.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $4.83 M(-47.4%) | $23.41 M(+0.3%) |
| June 2018 | - | $9.18 M(+71.0%) | $23.35 M(+28.0%) |
| Mar 2018 | - | $5.37 M(+32.8%) | $18.24 M(-12.6%) |
| Dec 2017 | $20.86 M(-14.4%) | $4.04 M(-15.1%) | $20.86 M(-3.4%) |
| Sept 2017 | - | $4.76 M(+17.2%) | $21.59 M(-6.0%) |
| June 2017 | - | $4.06 M(-49.1%) | $22.98 M(-4.4%) |
| Mar 2017 | - | $7.99 M(+67.2%) | $24.03 M(-1.4%) |
| Dec 2016 | $24.36 M(+10.2%) | $4.78 M(-22.3%) | $24.36 M(-2.4%) |
| Sept 2016 | - | $6.15 M(+20.2%) | $24.95 M(-5.6%) |
| June 2016 | - | $5.11 M(-38.5%) | $26.44 M(+0.6%) |
| Mar 2016 | - | $8.32 M(+54.8%) | $26.28 M(+18.9%) |
| Dec 2015 | $22.11 M(+176.4%) | $5.37 M(-29.6%) | $22.11 M(+9.9%) |
| Sept 2015 | - | $7.63 M(+53.9%) | $20.11 M(+35.2%) |
| June 2015 | - | $4.96 M(+19.7%) | $14.88 M(+30.4%) |
| Mar 2015 | - | $4.14 M(+22.6%) | $11.41 M(+42.7%) |
| Dec 2014 | $8.00 M(+348.6%) | $3.38 M(+41.0%) | $8.00 M(+37.7%) |
| Sept 2014 | - | $2.40 M(+60.5%) | $5.81 M(+58.3%) |
| June 2014 | - | $1.49 M(+105.8%) | $3.67 M(+54.9%) |
| Mar 2014 | - | $726.00 K(-39.0%) | $2.37 M(+32.8%) |
| Dec 2013 | $1.78 M(+232.6%) | $1.19 M(+361.2%) | $1.78 M(+200.7%) |
| Sept 2013 | - | $258.00 K(+33.0%) | $593.00 K(+77.0%) |
| June 2013 | - | $194.00 K(+37.6%) | $335.00 K(+137.6%) |
| Mar 2013 | - | $141.00 K | $141.00 K |
| Dec 2012 | $536.00 K | - | - |
FAQ
- What is Adverum Biotechnologies annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Adverum Biotechnologies?
- What is Adverum Biotechnologies annual SG&A year-on-year change?
- What is Adverum Biotechnologies quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Adverum Biotechnologies?
- What is Adverum Biotechnologies quarterly SG&A year-on-year change?
- What is Adverum Biotechnologies TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Adverum Biotechnologies?
- What is Adverum Biotechnologies TTM SG&A year-on-year change?
What is Adverum Biotechnologies annual selling, general & administrative expenses?
The current annual SG&A of ADVM is $49.91 M
What is the all time high annual SG&A for Adverum Biotechnologies?
Adverum Biotechnologies all-time high annual selling, general & administrative expenses is $64.44 M
What is Adverum Biotechnologies annual SG&A year-on-year change?
Over the past year, ADVM annual selling, general & administrative expenses has changed by -$7.94 M (-13.73%)
What is Adverum Biotechnologies quarterly selling, general & administrative expenses?
The current quarterly SG&A of ADVM is $9.78 M
What is the all time high quarterly SG&A for Adverum Biotechnologies?
Adverum Biotechnologies all-time high quarterly selling, general & administrative expenses is $21.93 M
What is Adverum Biotechnologies quarterly SG&A year-on-year change?
Over the past year, ADVM quarterly selling, general & administrative expenses has changed by -$4.01 M (-29.06%)
What is Adverum Biotechnologies TTM selling, general & administrative expenses?
The current TTM SG&A of ADVM is -$3.82 B
What is the all time high TTM SG&A for Adverum Biotechnologies?
Adverum Biotechnologies all-time high TTM selling, general & administrative expenses is $66.20 M
What is Adverum Biotechnologies TTM SG&A year-on-year change?
Over the past year, ADVM TTM selling, general & administrative expenses has changed by -$3.87 B (-7618.42%)